Nutritional parameters for patients with head and neck cancer

Anticancer Research

Volumn 32, Issue 5, 2012, Pages 2119-2124

  Büntzel, Jens ^a,b,f   Krauß, Tina ^b   Büntzel, Heike ^a   Küttner, Klaus ^b   Fröhlich, Dietmar ^b   Oehler, Wolfgang ^a   Glatzel, Michael ^b,c,h   Wackes, Matthias ^d   Putziger, Jens ^e   Micke, Oliver ^f   Kisters, Klaus ^g   Mücke, Ralph ^f  

^a Sudharz Hospital   (Germany)

^b Municipal Hospital   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

^d Regional Tumor Registration Base   (Germany)

^e Leipziger Modell ^*  (Germany)

^f FRANZISKUS HOSPITAL   (Germany)

^g ST ANNA HOSPITAL   (Germany)

^h KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

Bioimpedance analysis; Head and neck cancer; Nutritional status; Weight loss

Indexed keywords

CARBOPLATIN;

ADULT; AGED; ARTICLE; BIOIMPEDANCE; BIOMETRY; BODY MASS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; IMPEDANCE; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; NUTRITIONAL PARAMETERS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ELECTRIC IMPEDANCE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; RETROSPECTIVE STUDIES; SKINFOLD THICKNESS; SURVIVAL RATE;

EID: 84861484174     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Becker N and Wahrendorf J: Krebsatlas der Bundesrepublik Deutschland. Springer, Berlin 1998.
2. Micke O, Bruns F, Schäfer U, Horst E, Büntzel J and Willich N: The clinical value of squamous cell carcinoma antige in patients irradiated for locally advanced cancer of the head and neck. Anticancer Res 23: 907-912, 2003.
3. Kratzer T, Büntzel J and Küttner K: Tumor cachexia in head and neck cancer: incidence, treatment and prognostic impact. In: Alvarez Vicent JJ (ed.). First World Congress on Head and Neck Oncology. Monduzzi, Bologna, pp. 1093-1098, 1998.
4. Giannousi Z, Gioulbasanis I, Pallis AG, Xyrafas A, Dalliani D, Kalbakis K, Papadopoulos V, Mavroudis D, Georgoulias V and Papandreou CN: Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis. Support Care Cancer. 2011 Oct 1. [Epub ahead of print] PMID: 21959842.
5. Lochs H, Allison SP, Meier R, Pirchlich M, Kondrup J, Schneider St, van den Berghe G and Pichard C: Introductory to the ESPEN Guidelines on enteral nutrition: terminology, definitions and general topics. Clin Nutr 25: 180-186, 2006. (Pubitemid 43811689)
6. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R and Anker SD: Cachexia: a new definition. Clin Nutr 27: 793-799, 2008.
7. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z; Ad Hoc ESPEN Working Group. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 22: 321-336, 2003. (Pubitemid 36701649)
8. Jackson AS and Pollock ML: Generalized equations for predicting body density of men. Brit J Nutr 40: 497-504, 1978. (Pubitemid 9055340)
9. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AM and Pichard C: Composition of the ESPEN Working Group Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr 23: 1226-1243, 2004. (Pubitemid 39243041)
10. Piccoli A, Rossi B and Pillon G: A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int 46: 534-539, 1994. (Pubitemid 24253064)
11. Ott M, Fischer H, Polat H, Helm EB, Frenz M, Caspary WF and Lembcke B: Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immun Defic Syndr Hum Retrovirol 9: 20- 25, 1995.
12. Schaap LA, Pluijm SM, Deeg DJ and Visser M: Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119: 526.e9-17, 2006.
13. Büntzel J, Bruns F, Glatzel M, Garayev A, Mücke R, Kisters K, Schäfer U, Schönekaes K and Micke O: Zinc concentrations in serum during head and neck cancer progression. Anticancer Res 27: 1941-1943, 2007. (Pubitemid 46954703)